Skip to main content
CDC Website

Health Professionals

Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT)

This handout contains information for patients that are prescribed the 3HP regimen for the treatment of latent TB infection. The 3HP regimen is a 3-month once weekly regimen of isoniazid and rifapentine. The handout includes space to record the patient's doctor/clinic contact information. 

Global tuberculosis report 2020

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.

Treatment for Latent Tuberculosis (TB) Infection: Rifampin

This handout contains information for patients that are prescribed the 4-month daily regimen of rifampin (4R) for the treatment of latent TB infection. The handout includes space to record the patient's doctor/clinic contact information. 

Tips for Treating Latent TB Infection in Children

This fact sheet includes information on treating latent TB infection in children, including the treatment regimens, administration tips, and monitoring recommendations.

Communicating about Public Health in Times of Crisis: Strategies for TB Programs and Staff during the COVID-19 Pandemic

This webinar focuses on risk communication around TB during the COVID-19 pandemic. The learning objectives for this webinar are:
• Recognize the emotional and psychological impact of the COVID-19 pandemic on health workers and TB patients
• Apply risk communication principles to develop messages on TB and COVID-19 for front-line health workers, patients, and contacts
• Use tailored approaches for communicating with health workers, TB patients, contacts so appropriate TB care can be provided